Circassia Group Plc Director/PDMR Shareholding (5209U)
April 06 2021 - 6:56AM
UK Regulatory
TIDMCIR
RNS Number : 5209U
Circassia Group Plc
06 April 2021
Circassia Group plc
Director/PDMR Shareholding
Oxford, UK - 6 April 2021: Circassia Group plc ("Circassia" or
"the Company") (LSE: CIR), a medical device company focused on
respiratory diagnostics and monitoring, today announces that on 1
April 2021, Ian Johnson, Executive Chairman, purchased 100,000
Ordinary Shares at a price of 28.50 pence per share, Michael
Roller, Chief Financial Officer purchased 175,000 Ordinary Shares
at a price of 28.91 pence per share and Jonathan Emms, Chief
Operating Officer, purchased 67,928 Ordinary Shares at a price of
29.42 pence per share. In addition to this, on 6 April 2021, Ian
Johnson purchased 100,000 Ordinary Shares at a price of 29.25 pence
per share.
Following these purchases, Ian Johnson holds 400,000 Ordinary
Shares (0.10% of the issued share capital of the Company), Michael
Roller holds 375,000 Ordinary Shares (0.09% of the issued share
capital of the Company) and Jonathan Emms holds 667,928 Ordinary
Shares (0.16% of the issued share capital of the Company).
Additional detail is provided below in accordance with the
requirements of UK MAR.
Contacts
Circassia Tel: +44(0)1865 405566
Ian Johnson, Executive Chairman
Michael Roller, Chief Financial Officer
Sarah Duncan, Company Secretary
N+1 Singer (Nominated Adviser and Tel: +44 (0) 20 7496
Broker) 3000
Aubrey Powell / Jen Boorer / Hannah
Woodley
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name (1) Ian Johnson
(2) Michael Roller
(3) Jonathan Emms
=============================== ==================================
2. Reason for the notification
===================================================================
a. Position/status (1) Executive Chairman
(2) Chief Financial Officer
(3) Chief Operating Officer
=============================== ==================================
b. Initial notification/Amendment Initial notification
=============================== ==================================
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
===================================================================
a. Name Circassia Group plc
=============================== ==================================
b. LEI 2138006YAT138TOGA556
=============================== ==================================
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
===================================================================
a. Description of the Ordinary Shares of 0.08p each
Financial instrument, type
of instrument GB00BJVD3B28
Identification code
=============================== ==================================
b. Nature of the transaction Purchase of Ordinary Shares
=============================== ==================================
c. Price(s) and volume(s) Price(s) Volume(s)
(1a ) 28.50p (1a) 100,000
(1b)* 29.25p (1b)* 100,000
(2a) 28.00p (2a) 2,500
(2b) 28.92p (2b) 172,500
(3) 29.42p (3) 67,928
---------------
=============================== ==================================
d. Aggregated information Price(s) Volume(s)
* Aggregated volume (1 ) 28.88p (1) 200,000
(2) 28.91p (2) 175,000
(3) 29.42p (3) 67,928
* Price -------------
=============================== ==================================
e. Date of the transaction 01/04/2021
*06/04/2021
=============================== ==================================
f. Place of the transaction London Stock Exchange, AIM
=============================== ==================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFQLFBFZLEBBE
(END) Dow Jones Newswires
April 06, 2021 07:56 ET (11:56 GMT)
Circassia (LSE:CIR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2023 to Apr 2024
